EUVIMEDEUVIMED entdecken
Crossref

Dose-dependent CXCR4 inhibition in ovarian cancer cellular models reveals a paradoxical response characterized by subtype-specific oncogenic suppression and stress-induced adaptive rebound

Ayman Alzu'bi, Ejlal Abu-El-Rub, Ghada Alomari, Yara Ghawanmeh, Rawan Almazari, Ali Hmedat, Raed M Al-Zoubi

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-12917-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Ayman Alzu'bi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan. ayman.alzubi@yu.edu.jo. Hauptthemen laut MEDLINE: Receptors, CXCR4, Ovarian Neoplasms. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The CXCL12/CXCR4 signaling axis drives ovarian cancer progression, metastasis, and chemoresistance, making it a key therapeutic target. However, the biological consequences of prolonged high-dose inhibition remain poorly characterized. This study investigated the dose-dependent molecular and functional effects of prolonged exposure to the selective CXCR4 antagonist USL311 in heterogeneous ovarian cancer models (ES2 and HAY cell lines). METHODS: Cells were treated with 50, 75, or 100 µM USL311 for 72 h. Western blot, immunofluorescence, cytotoxicity, and wound-healing assays evaluated signaling cascades, protein expressions, and functional outcomes. RESULTS: CXCR4 inhibition triggered highly discrete, lineage-specific molecular responses. ES2 cells exhibited a prominent biphasic pattern; 50 µM USL311 significantly suppressed CXCR4 and Cyclin D1 expression, but higher concentrations induced a paradoxical rebound expression driven by a HIF1α-dependent adaptive stress mechanism, despite p-AKT suppression and marked cytotoxicity. Conversely, HAY cells bypassed this cascade via a HIF1α-independent pathway, initiating a compensatory escape network marked by a structural rebound in p-AKT activation and significant upregulation of metastatic enzymes MMP2 and MMP9 under identical conditions. CONCLUSION: CXCR4 inhibition induces highly complex, concentration- and cell-line-dependent biological responses. Moderate inhibition effectively suppressed oncogenic signaling pathways, whereas excessive inhibition triggered paradoxical compensatory responses that vary across ovarian cancer subtypes. These findings highlight the critical importance of therapeutic dose optimization and provide crucial mechanistic insights into the limitations of high-dose CXCR4-targeted therapy in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR4Ovarian NeoplasmsFemaleHumansCell Line, TumorSignal TransductionGene Expression Regulation, NeoplasticHypoxia-Inducible Factor 1, alpha SubunitChemokine CXCL12Proto-Oncogene Proteins c-aktCell ProliferationDose-Response Relationship, Drug

Stichwörter der Autor:innen

AKT signalingBiphasic responseCXCR4Cellular subtypesCyclin D1ES2HAYHIF1αMetastasisOvarian cancerParadoxical reboundUSL311

Substanzen

Receptors, CXCR4CXCR4 protein, humanHypoxia-Inducible Factor 1, alpha SubunitChemokine CXCL12Proto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan. ayman.alzubi@yu.edu.jo.
  • Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan. ejlal.abuelrub@yu.edu.jo.
  • Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid, 211-63, Jordan.
  • Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
  • Department of Pharmaceutics and Pharmacological Technology, Faculty of Pharmacy, Yarmouk University, Irbid, 21163, Jordan.
  • Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.

Zitieren

APA

Alzu'bi, A., Abu-El-Rub, E., Alomari, G., Ghawanmeh, Y., Almazari, R., Hmedat, A., & Al-Zoubi, R. M. (2026). Dose-dependent CXCR4 inhibition in ovarian cancer cellular models reveals a paradoxical response characterized by subtype-specific oncogenic suppression and stress-induced adaptive rebound. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12917-1

Vancouver

Alzu'bi A, Abu-El-Rub E, Alomari G, Ghawanmeh Y, Almazari R, Hmedat A, et al. Dose-dependent CXCR4 inhibition in ovarian cancer cellular models reveals a paradoxical response characterized by subtype-specific oncogenic suppression and stress-induced adaptive rebound. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12917-1

BibTeX
@article{Alzubi2026,
  author = {Alzu'bi, Ayman and Abu-El-Rub, Ejlal and Alomari, Ghada and Ghawanmeh, Yara and Almazari, Rawan and Hmedat, Ali and Al-Zoubi, Raed M},
  title = {Dose-dependent CXCR4 inhibition in ovarian cancer cellular models reveals a paradoxical response characterized by subtype-specific oncogenic suppression and stress-induced adaptive rebound},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-12917-1}
}
Kostenlos starten →